ROCKVILLE, MD — July 06, 2021 — Psomagen, Inc., a CLIA-certified genetic analysis service provider, is adapting to the public’s changing COVID-19 testing needs by expanding its SARS-CoV-2 diagnostic services. In addition to its GutBiome and Gene Trait testing, the company now offers direct-to-consumer saliva collection kits for diagnosing COVID-19 for adults age 18 and […]
Should we? These experts answer that question in Part 2 of our Talking Techniques podcast with BioTechniques: David Dimmock Senior Medical Director at Rady Children’s Institute of Genomic Medicine Christine Stanley Chief Director of Clinical Genomics at Variantyx Take Ogawa Chief Commercial Officer at Psomagen RELATED CONTENT: 🎥 VIDEO Whole-Genome Sequencing for Precision Medicine […]
Join us as we talk with experts in rare disease research, clinical practice, and WGS technology about how its bringing disease diagnostics and treatment to life: David Dimmock Senior Medical Director at Rady Children’s Institute of Genomic Medicine Alan Beggs Director of The Manton Center for Orphan Disease Research at Boston Children’s Hospital Sir Edwin […]
This video explores how clinical whole genome sequencing (WGS) is bringing precision medicine to life with new treatments, advanced diagnostics, and more. Join us as we introduce the technique’s impact from academic research to clinical application. RELATED CONTENT: 🎙 PODCAST Talking Techniques: Episode 1 Whole-Genome Sequencing: Navigating the ‘Diagnostic Odyssey’ in Rare Disease Research […]
ROCKVILLE, MD — April 13 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is collaborating with Swift Biosciences (now part of Integrated DNA Technologies), a pioneer in the development of research-use-only library preparation kits, to offer comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS). Early in the pandemic, public health […]
ROCKVILLE, MD — February 23, 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services. These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology […]
As one of the newest members of the COVID-19 Testing Industry Consortium, we wanted to share with you the results of our Back-to-Work survey. The survey, conducted last fall, represents the experiences of 77 organizations across the United States. We hope the information inside will help us understand the intricacies of the ongoing pandemic challenges […]
We are proud to share the many number of valuable publications that we have released over the years. Feel free to read below to see what we have been working on and discovering since 2004. 2016 Jeong-Sun Seo et al. De novo assembly and phasing of a Korean human genome. Nature 538, 243-247 (2016). 2012 […]
We are proud to support the Sturge-Weber Foundation. Please watch this video to learn more about our partnership with them!
New Company Name Combines Mind, Body, and Genomics ROCKVILLE, MD — June 9, 2019 — Macrogen USA, a bioscience research firm that provides advanced research and clinical DNA sequencing services to U.S., recently announced a company name change. Macrogen USA is now officially Psomagen Inc: Humanizing Phenomics 120. Learn about Psomagen, Inc.:Psomagen.com “Macrogen has […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.